Valneva SE (VALN) Return on Sales (2021 - 2026)

Valneva SE's (VALN) quarterly Return on Sales came in at 0.01% in Q1 2026, down 1.0% year-on-year from 0.01% in Q1 2025, and up 23.35% quarter-over-quarter from 0.01% in Q4 2025.

Valneva SE (VALN) Return on Sales (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Return on Sales across 6 years of filings, most recently posting 0.01% for Q1 2026.

  • Return on Sales for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
  • Return on Sales came in at 0.01% for Q1 2026 at Valneva SE, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q1 2024 to a low of 0.08% in Q2 2022.
  • The 5-year median for Return on Sales is 0.01% (2024), against an average of 0.01%.
  • Peak annual rise in Return on Sales reached 13 bps in 2022, while the deepest fall reached 11 bps in 2022.
  • Valneva SE's Return on Sales stood at 0.01% in 2022, then surged by 48 bps to 0.01% in 2023, then declined by 16 bps to 0.01% in 2024, then slumped by 78 bps to 0.01% in 2025, then rose by 23 bps to 0.01% in 2026.
  • The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.00%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 0.00%
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.00%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -0.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.02%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 -0.01%
Sep 30, 2024 0.00%
Jun 30, 2024 -0.01%
Mar 31, 2024 0.02%
Dec 31, 2023 -0.01%
Sep 30, 2023 -0.01%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.01%
Dec 31, 2022 -0.01%
Sep 30, 2022 0.02%
Jun 30, 2022 -0.08%
Mar 31, 2022 -0.02%
Dec 31, 2021 0.10%
Sep 30, 2021 -0.11%
Jun 30, 2021 -0.04%